Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Oct;13(10):859-66.
doi: 10.1016/S1473-3099(13)70164-6. Epub 2013 Aug 9.

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study

Chantal B E M Reusken  1 , Bart L Haagmans, Marcel A Müller, Carlos Gutierrez, Gert-Jan Godeke, Benjamin Meyer, Doreen Muth, V Stalin Raj, Laura Smits-De Vries, Victor M Corman, Jan-Felix Drexler, Saskia L Smits, Yasmin E El Tahir, Rita De Sousa, Janko van Beek, Norbert Nowotny, Kees van Maanen, Ezequiel Hidalgo-Hermoso, Berend-Jan Bosch, Peter Rottier, Albert Osterhaus, Christian Gortázar-Schmidt, Christian Drosten, Marion P G Koopmans
Affiliations
Comparative Study

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study

Chantal B E M Reusken et al. Lancet Infect Dis. 2013 Oct.

Abstract

Background: A new betacoronavirus-Middle East respiratory syndrome coronavirus (MERS-CoV)-has been identified in patients with severe acute respiratory infection. Although related viruses infect bats, molecular clock analyses have been unable to identify direct ancestors of MERS-CoV. Anecdotal exposure histories suggest that patients had been in contact with dromedary camels or goats. We investigated possible animal reservoirs of MERS-CoV by assessing specific serum antibodies in livestock.

Methods: We took sera from animals in the Middle East (Oman) and from elsewhere (Spain, Netherlands, Chile). Cattle (n=80), sheep (n=40), goats (n=40), dromedary camels (n=155), and various other camelid species (n=34) were tested for specific serum IgG by protein microarray using the receptor-binding S1 subunits of spike proteins of MERS-CoV, severe acute respiratory syndrome coronavirus, and human coronavirus OC43. Results were confirmed by virus neutralisation tests for MERS-CoV and bovine coronavirus.

Findings: 50 of 50 (100%) sera from Omani camels and 15 of 105 (14%) from Spanish camels had protein-specific antibodies against MERS-CoV spike. Sera from European sheep, goats, cattle, and other camelids had no such antibodies. MERS-CoV neutralising antibody titres varied between 1/320 and 1/2560 for the Omani camel sera and between 1/20 and 1/320 for the Spanish camel sera. There was no evidence for cross-neutralisation by bovine coronavirus antibodies.

Interpretation: MERS-CoV or a related virus has infected camel populations. Both titres and seroprevalences in sera from different locations in Oman suggest widespread infection.

Funding: European Union, European Centre For Disease Prevention and Control, Deutsche Forschungsgemeinschaft.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Reactivity of livestock sera with three coronavirus S1 antigens Fluorescent intensities per antigen at a serum dilution of 1/20. Black lines indicate median. Dashed line is cutoff of the assay. RFU=relative fluorescence units. SARS-CoV=severe acute respiratory syndrome coronavirus. HCoV=human coronavirus. MERS-CoV=Middle East respiratory syndrome coronavirus.
Figure 2
Figure 2
MERS-CoV and human coronavirus OC43 or bovine coronavirus cross-reactivity Combinations of the mean fluorescent intensities of reactions of sera with MERS-CoV and human coronavirus OC43 antigens from 105 Spanish dromedary camels (A). plaque reduction neutralisation tests for bovine coronavirus and MERS-CoV (B): two representative sera are shown (numbers 15 and 5, corresponding to camel ID numbers in table 2) in dilutions of 1/40, 1/160, and 1/640 as well as the virus input control. All samples were tested in duplicates (only one well shown) and titres were expressed as the serum dilution resulting in a plaque reduction of at least 90%. IgG reactivity of both camel sera to MERS-CoV antigen and human coronavirus OC43 antigen in a two-step dilution series in the microarray (C). IgG reactivity of two two-step serially diluted Omani dromedary camel sera with human coronavirus EMC antigen and human coronavirus OC43 antigen in the microarray (D). RFU=relative fluorescence units. MERS-CoV=Middle East respiratory coronavirus.
See this image and copyright information in PMC

Comment in

  • MERS-CoV: the intermediate host identified?
    de Wit E, Munster VJ. de Wit E, et al. Lancet Infect Dis. 2013 Oct;13(10):827-8. doi: 10.1016/S1473-3099(13)70193-2. Epub 2013 Aug 9. Lancet Infect Dis. 2013. PMID: 23933068 Free PMC article. No abstract available.
  • Missing information in animal surveillance of MERS-CoV.
    Nishiura H, Ejima K, Mizumoto K. Nishiura H, et al. Lancet Infect Dis. 2014 Feb;14(2):100. doi: 10.1016/S1473-3099(13)70699-6. Lancet Infect Dis. 2014. PMID: 24457168 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. WHO Global Alert and Response (GAR): novel coronavirus infection. http://www.who.int/csr/don/2013_08_01/en/index.html (accessed Aug 1, 2013).
    1. Albarrak AM, Stephens GM, Hewson R, Memish ZA. Recovery from severe novel coronavirus infection. Saudi Med J. 2012;33:1265–1269. - PubMed
    1. Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med. 2013;368:2487–2494. - PubMed
    1. Drosten C, Seilmaier M, Corman VM. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013 doi: 10.1016/S1473-3099(13)70154-3. published online June 17. - DOI - PMC - PubMed
    1. Buchholz U, Müller MA, Nitsche A. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October–November 2012. Euro Surveill. 2013;18:20406. - PubMed

Publication types